BMEA PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

BMEA ▲ +53.28% at T+20d

NEUTRAL call ✓ call won +53.28% · α vs SPY +45.42% · entry $1.22 → $1.87

Next anchor: T+60d in 28d

Currently $1.37 · +11.89% from $1.22 entry

Entry anchored
Mar 24, 03:59 PM ET
via Databento tick

T+1d

+12.30%

call +12.30% · α +14.06%

$1.37

settled 8w ago

T+5d

+22.13%

call +22.13% · α +22.37%

$1.49

settled 7w ago

T+20d

+53.28%

call +53.28% · α +45.42%

$1.87

settled 29d ago

T+60d

—

call — · α —

—

in 28d

Price Chart

Loading chart...

Executive Summary

Biomea Fusion, Inc. (BMEA) reported its full-year 2025 financial results and provided a business update. As a clinical-stage company focused on diabetes and obesity, it has not generated revenue from commercial operations, and the release contains no financial figures or guidance that materially alter the company's trajectory.

Actionable Insight

Traders should await the full 10-K filing for actual financial metrics such as cash runway, net loss, and R&D expenditures. The lack of disclosed data in the press release limits immediate trading implications.

Key Facts

Biomea Fusion is a clinical-stage biopharma company with no commercial revenue.
The press release announces financial results for 2025 but discloses no actual financial data (e.g., cash position, R&D spend, net loss, or cash runway).
No updates on clinical trial progress, regulatory milestones, or upcoming catalysts were provided.

Financial Impact

No material financial data disclosed

Risk Factors

Lack of disclosed financials increases uncertainty around cash runway and sustainability.
No clinical or regulatory updates reduce visibility into near-term value drivers.

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3261720

7 reports for BMEA

T+1T+5T+20T+60

50% Hit rate 2 of 4 directional calls best @ T+5▲ +15.03%Mar 31, 2026

Filters

Reports for BMEA — sortable, filterable
	Type				Now
May 11, 2026 9d ago	8-K NEUTRAL ★ 4/10	$1.58 $1.25	▼ −20.89%	▼ −20.96%	$1.37 (−13.61%)
May 11, 2026 9d ago	Press Release NEUTRAL ★ 5/10	$1.58 $1.25	▼ −20.89%	▼ −20.96%	$1.37 (−13.61%)
Apr 28, 2026 23d ago	8-K BULLISH ★ 7/10	$1.53 $1.48	▼ −3.27%	▼ −4.96%	$1.37 (−10.78%)
Apr 27, 2026 23d ago	Press Release BULLISH ★ 6/10	$1.53 $1.48	▼ −3.27%	▼ −4.96%	$1.37 (−10.78%)
Mar 31, 2026 7w ago	Press Release BULLISH ★ 7/10	$1.53 $1.76	▲ +15.03%	▲ +11.09%	$1.37 (−10.78%)
Mar 24, 2026 8w ago	Press Release NEUTRAL ★ 3/10	$1.22 $1.49	▲ +22.13%	▲ +22.37%	$1.37 (+11.89%)
Feb 25, 2026 12w ago	8-K BULLISH ★ 7/10	$1.41 $1.39	▼ −1.42%	▼ −0.32%	$1.37 (−3.19%)

US Market Status

Market Open — Closes in 4h 38m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access